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Abstract
Background: The lack of a holistic approach to palliative care can lead to a fractured sense of dignity at the end of
life, resulting in depression, hopelessness, feelings of being a burden to others, and the loss of the will to live
among terminally ill patients. Building on the clinical foundation of Dignity Therapy, together with the empirical
understanding of dignity-related concerns of Asian families facing terminal illness, a novel Family Dignity Intervention
(FDI) has been developed for Asian palliative care. FDI comprises a recorded interview with a patient and their primary
family caregiver, which is transcribed, edited into a legacy document, and returned to the dyads for sharing with the
rest of the patient’s family. The aims of this study are to assess the feasibility, acceptability and potential effectiveness of
FDI in reducing psychosocial, emotional, spiritual, and psychophysiological distress in community-dwelling and
in-patient, Asian, older terminally ill patients and their families living in Singapore.
Methods/design: An open-label randomized controlled trial. One hundred and twenty-six patient-family dyads
are randomly allocated to one of two groups: (1) an intervention group (FDI offered in addition to standard
psychological care) and (2) a control group (standard psychological care). Both quantitative and qualitative
outcomes are assessed in face-to-face interviews at baseline, 3 days and 2 weeks after intervention, as well as
during an exit interview with family caregivers at 2 months post bereavement. Primary outcome measures
include sense of dignity for patients and psychological distress for caregivers. Secondary outcomes include
meaning in life, quality of life, spirituality, hopefulness, perceived support, and psychophysiological wellbeing,
as well as bereavement outcomes for caregivers. Qualitative data are analyzed using the Framework method.
Discussion: To date, there is no available palliative care intervention for dignity enhancement in Asia. This
first-of-its-kind study develops and tests an evidence-based, family driven, psycho-socio-spiritual intervention
for enhancing dignity and wellbeing among Asian patients and families facing mortality. It addresses a critical
gap in the provision of holistic palliative care. The expected outcomes will contribute to advancements in
both theories and practices of palliative care for Singapore and its neighboring regions while serving to inform similar
developments in other Asian communities.
Trial registration: ClinicalTrials.gov, ID: NCT03200730. Registered on 26 June 2017.
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Background
The defining principles of palliative care, including
symptom control as well as psychological and spiritual
support, aim to optimize quality of life and promote
death with dignity [1]. However, most conventional pal-
liative care interventions are heavily medically oriented,
focusing predominantly on symptom management and
control of physical pain, without addressing the psycho-
social, emotional, and spiritual pains of the dying. The
lack of a holistic approach to palliative care can lead to a
fractured sense of dignity at the end of life. According to
a vast body of academic literature conducted in the
West, an undermining of dignity among dying patients
is associated with high levels of depression, anxiety,
hopelessness, feelings of being a burden to others, as
well as the loss of the will to live [2, 3]. Conversely, pa-
tients deem a sense of control, hope, pride, self-respect,
and self-esteem to be among the most important facets
of facing death with dignity [4, 5]. An integrative review
of the empirical research that examined the meaning of
dying with dignity by Guo and Jacelon [6] supports these
findings, and echoes Erickson’s theory of psychosocial
development which highlights the need for elders to
reflect on their lives with a sense of closure, complete-
ness, and acceptance so as to experience ego integrity
rather than despair at the last stage of life [7]. Clearly,
palliative intervention must reach beyond the realm of
physical care to fully address the total pain of mortality
[8]. Yet, aside from the important work of religious cler-
gies and faith-based counselors, the World Health
Organization, together with numerous international
bodies like the Worldwide Palliative Care Alliance and
the Marie Curie Foundation, have repeatedly noted a
general lack of non-pharmacological, structured psycho-
social-spiritual interventions specifically designed to
lessen the suffering and existential distress that accom-
pany death and dying [9, 10].
Via interviews with older hospice patients in Canada,
Chochinov and his colleagues [11, 12] developed an em-
pirical model of dignity that identifies three major
categories of physical, psychosocial and existential issues
pertaining to one’s experience of dignity at life’s end.
This model further forms the foundation of a brief psy-
chotherapy to help reduce distress and promote dignity
[13]. Specifically, dignity therapy involves a semi-
structured interview with individual patients using nine
core questions that stem from the dignity model.
Patients are invited to respond to those questions that
resonate as meaningful to them, and this often includes
offering final words and remembrances to their loved
ones. The interview is conducted by a trained therapist,
which is recorded, transcribed, and edited. A follow-up
session is held shortly after for the patient to review the
edited transcript and to make conclusive modifications if
required. Upon final revision, the patient is given a hard
copy of the “generativity” document, and asked to iden-
tify with whom the document should be shared or
bequeathed following death. A series of evaluation stud-
ies on Dignity Therapy conducted with hospice patients
in Canada, the United States, and Australia generated
positive findings for both patients and their families in
elevating one’s sense of dignity, heightening life’s mean-
ing, increasing the will to live, and providing comfort
through grief [14, 15].
Both the dignity model and dignity therapy are well
received and profoundly influential in the development
of palliative care practices and policies in Western soci-
eties. However, the meaning of dignity varies across
cultures and different ethnic groups due to its value-
laden nature. Recognizing the critical role that families
plays in rendering end-of-life care in Eastern societies as
well as the longstanding emphasis of collectivism over
individualism in Asia, Ho and his colleagues conducted
an extensive body of research investigating the construct
of dignity from the perspectives of older, Asian termin-
ally ill patients and their family caregivers [16, 17].
While the findings from these investigations mostly sup-
ported the Western dignity model and its three core
conceptual categories related to the physical, psycho-
social, and existential domains, family relationships and
family processes have emerged as critical components of
dignity in the Asian model. Particularly, it was reported
that older Asian patients experience great distress as
they feel trapped in the liminal space between living and
dying, challenged by limited mobility and increased
dependency. According to Ho et al. [18], in order to
maintain and promote dignity at life’s final margin, one
must strengthen patients’ spiritual plasticity through
helping them find meaning in their pain, let go of their
attachments, and establish moral transcendence with the
love and support of their families; equally important is
to help patients bolster their sense of family connect-
edness through creating a platform for expressing ap-
preciation, achieving reconciliation, fulfilling family
obligations, and establishing continuing bonds with
their descendants. Findings with family caregivers fur-
ther revealed that patients’ sense of dignity can be
enhanced through strengthening family integrity and
filial compassion, which involves the cultivation of
mutual support, reciprocal relationship, and altruistic
reverence gained through open communications and
exchanges with their loved ones [19]. Despite the
longing to rekindle family bonds at the end of life, it
was found that Asian patients and their families are
often reluctant to engage in dignity-enhancing dis-
courses as they feel constrained by unresolved family
conflicts, and most pertinently, the cultural taboos of
death. This has largely resulted in pragmatic
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communication and support that focus primarily on
physical care with little opportunities for emotional
connections.
Family, rather than the individual, is seen as the basic
unit of life in Asian cultures. Hence, in order to help
older terminally ill patients and their families reduce suf-
fering and achieve a sense of hope and meaning when
death draws near, family must become the driving
principle that guides dignity-enhancing interventions in
the Asian context [20]. Yet, despite increasing demands
for holistic palliative care services in Asia with wide-
spread population aging in the region, no such interven-
tion is available. Building on the clinical foundation of
Dignity Therapy together with the empirical understand-
ing of dignity-related concerns of Asian families facing
terminal illness, a novel “Family Dignity Intervention”
(FDI) has been developed. The design of FDI is funda-
mentally based on the Dignity Therapy protocol, but
instead of an individual model of therapy, FDI adopts a
patient-family dyad model to facilitate open dialogue be-
tween patients and their family caregivers, one that
aspires to strengthen family connectedness and filial
compassion via creating a supportive platform for the
expression of appreciation, achieving reconciliation, for-
tifying family bonds, and passing on transcendental
values and wisdom for establishing lasting legacies. The
ultimate goal of FDI is to offer a viable dignity-enhancing
intervention to promote holistic palliative care in Asia,
one that addresses the psycho-socio-spiritual needs of
Asian families who are not strong in their expression of
intimacy and articulation of emotions in the face of
mortality.
Aim and objectives
Based on the Medical Research Council guidance for
developing and evaluating complex intervention [21],
the aims of the current study are to assess the feasibility,
acceptability, and potential effectiveness of FDI in redu-
cing psychosocial, emotional, spiritual, and psycho-
physiological distress in community-dwelling and in-
patient, Asian, older terminally ill patients and their
families living in Singapore. The specific objectives
are to:
1. Assess the effectiveness of FDI for increasing older
terminally ill patients’ sense of dignity, hope, life
meaning, quality of life, promoting psychophysiological
wellbeing, and reducing psychosocial distress
2. Assess the effectiveness of FDI for increasing family
caregivers’ sense of hope, life meaning, quality of life,
promoting psychophysiological wellbeing, and
improving bereavement outcomes, as well as
reducing psychosocial distress
3. Assess the feasibility and acceptability of FDI for
Asian palliative care in the Singaporean context, and
4. Develop a standardized protocol for further empirical
research that tests intervention effectiveness,




This study adopts an open-label randomized controlled
trial design comprising of two groups: (1) an intervention
group (FDI offered in addition to standard psychological
care), and (2) a control group (standard psychological care
which includes emotional support and psychosocial home
visits). Consenting participants including one patient and
one family caregiver from one family unit (i.e., patient-
family dyad) are randomly allocated to one of these two
groups after baseline assessment meetings have been con-
ducted. The Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) Checklist for the study
is included as an Additional file 1.
Randomization
Randomization is conducted by an independent statisti-
cian. Treatment allocation (FDI or control) is performed
by block randomization with a fixed block size of 2.
Allocation concealment is facilitated by using sequen-
tially numbered, opaque, sealed envelopes for consecu-
tive and eligible families. To reduce the risk of bias, the
researcher opens the next envelope to ascertain which
group a patient-family dyad has been allocated to after
baseline measures have been collected.
Study sites
Study participants are recruited from two major hospice
service providers and their various satellite centers across
Singapore. First, Dover Park Hospice (DPH) is a secular,
non-profit organization that offers both in-patient and
homecare hospice services to terminally ill patients and
their families. It is one of the largest standalone hospice in
the country with over 50 in-patient beds and extensive
homecare provision. Second, Hospice Care Singapore
(HCA) is a registered charity that offers daycare and
homecare hospice services to terminally ill patients and
their families. With two day care centers and four satellite
service centers stationed across the country, they provide
nationwide coverage to all Singaporeans. Both DPH and
HCA are funded publicly and via donations; service ad-
missions are based on physician referrals and means-
testing mechanisms as ascribed by the Singapore Ministry
of Health. Both service providers house a team of pallia-
tive care specialists including physicians, nurses, social
workers, and counselors to provide round-the-clock sup-
port to individuals and families facing the end of life.
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Participants
The sample comprises 126 Asian families in Singapore,
which would include participants of Chinese, Malay,
Indian and other Eurasian ethnicities [22]. Each family
includes a patient-family dyad: (1) one older terminally
ill patient and (2) one identified family member who
the patient considers to be their primary or trusted
caregiver. Participants are recruited through the in-
patient, daycare, and homecare hospice service units of
DPH and HCA. Inclusion criteria include: patients
aged 60 years or above, diagnosed with a terminal ill-
ness, a life expectancy of less than 6 months, living in
the community and receiving hospice-provided home-
care or daycare, or residing in a long-term-care or hos-
pice facility and receiving hospice-provided palliative
care. One identified family member, who the patient
considers to be their primary caregiver, is also
recruited. Patients and family caregivers are screened
for spiritual or psychological distress, or loss of dignity;
however, these are assessed during baseline assess-
ments to explore their potential moderating effects on
the impact of FDI. Exclusion criteria include patients
and family caregivers who are deemed too ill to partici-
pate, unable to provide informed consent, suffer from
major cognitive disabilities, or are unable to under-
stand and communicate in English, Mandarin, or
Cantonese.
Sample size calculation
Allowing for an attrition rate of 40% at follow-up (a large
estimate due to end-of-life context and the potentiality of
patients dying before completion of intervention), a sample
of 126 families (N = 252; 126 patients and 126 family care-
givers) gives us 80% power to detect an effective size of 0.6
(common medium effect size estimate for psychotherapies)
[23] between the intervention and control group at the
(two-tailed test) 5% level of significance.
Intervention group
FDI is delivered by two research associates with a Mas-
ter’s degrees in counseling who have received Dignity
Therapy training conducted by Chochinov and his team.
Training includes the theoretical foundation of dignity,
an overview of the dignity therapy techniques, experien-
tial role-play, and editing of a generativity document.
The two research associates have also received training
on the Asian dignity model by Ho and his team, which
included the empirical understanding of dignity from
the perspectives of Asian families facing end of life, basic
family therapy, and meaning-oriented interview tech-
niques, as well as experiential role-play.
Table 1 provides a summary of the intervention proce-
dures of FDI. During the first baseline assessment meet-
ing, a brief framing session is conducted by the FDI
therapist with patient-family dyads assigned to the inter-
vention group so as to gauge the focus of therapy. Two
sets of question frameworks, one for patients and one
for caregivers, are shared with the dyads to provide them
with the opportunity to reflect on, and think about, their
responses (see Table 2). The questions focus on eliciting
patients’ life experiences in relation to their families,
while caregivers’ responses are used to enrich patients’
narratives. The framing session and the question frame-
works provide a flexible guide for the FDI therapist to
shape the intervention interview, based on the dyads’
interest.
The intervention interview session takes place 2 to
3 days after the baseline meeting. During the interview
using the question frameworks, the FDI therapist follows
the dyads’ cues, helping them to structure and organize
their thoughts. For example, the FDI therapist may ask
questions about time sequences, how events are related
to each other, facilitate the disclosure of cherished mem-
ories, and encourage the expression of appreciation and
reconciliation. The intervention interview lasts between
60 and 90 min; it is audio-recorded, quickly transcribed
Table 1 Session content of Family Dignity Intervention (FDI)
Session Content
1. Brief framing session • FDI question framework provided to patient-family dyad for reflection
• Therapist gauges the focus of therapy from the standpoint of the patient with input by the family caregiver in
preparation for the intervention interview
2. Intervention interview
session
• Recorded interview with patient-family dyad using the FDI question framework, which focuses on the patient’s
life experiences in the family context, with caregiver’s responses enriching patient’s narrative
• Therapist follows dyad’s cues, helps them structure and organize their thoughts, connects sequence of events, facilitates
disclosure of cherished memories, and encourages expression of appreciation and reconciliation
3. Transcript review
session
• Intervention interview is quickly transcribed verbatim and shaped into a coherent narrative by the therapist using a
formatted editing process
• Therapist meets with patient-family dyad to review the edited transcript, ensures it conveys the dyad’s overall message,
and finalizes editorial revisions
4. Family sharing session • The final transcript becomes a “legacy” document of the patient-family dyad
• Therapist organizes a family meeting with the dyad and their invited loved ones to an open reading of the legacy
document at a private location
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verbatim then shaped into a coherent narrative using
a formatted editing process. This includes clarifica-
tion, chronological corrections, tagging and editing
any content that might inflict significant harm on
family (after discussion with the dyads), and finding a
suitable ending for the document which is appropriate
to the dyads’ overall message. A transcript review
session is arranged 2 to 3 days later for the FDI ther-
apist to check the edited transcript with the dyads,
who are invited to make any editorial suggestions and
revisions. Once the transcript is finalized, it will be-
come a “legacy” document of the dyads, and a final
family sharing session is arranged for the dyads to
share and read this document to each other and their
loved ones. The entire FDI, from the brief framing
session, to the intervention interview session, the
transcript review session, and the final family sharing
session, is usually completed within 2 weeks.
Since the condition of a terminally ill patient fluctuates
rapidly, the timing of contacts and meetings can be
relaxed and rescheduled. If the patients’ condition deteri-
orates, meetings are rescheduled up to three times
before sensitively withdrawing them from the study. The
FDI therapist makes detailed notes of each intervention
sessions and documents any deviations from the FDI
protocol. One in two intervention transcripts is ran-
domly selected for review by the principle investigator
and one co-investigator for data monitoring, quality and
safety assurance. These mechanisms serve as an audit
trail as well as the foundation of the acceptability and
feasibility study.
Control group
Patient-family dyads in the control group receive three
psychosocial home visits (four for caregivers) to be ren-
dered by a designated research team member. Each visit
comprises a research assessment interview with basic
emotional support. Completing the assessment inter-
views provides participants with the opportunity to share
their feelings and emotions along their illness trajectory.
The extent to which they feel that sharing is therapeutic
is explored in the interviews.
Procedures
The recruitment and follow-up procedures are shown in
Fig. 1. Appointed research nurses of DPH and HCA are
asked to distribute research information pamphlets to all
patients and family caregivers eligible for the study,
based on their clinical assessments of patients using the
Karnofsky Performance Status Scale (KPSS) [24];
patients who received a score of 30 or below are consid-
ered too ill and ineligible to participate. At least 1 week
is given for full consideration to participate in the study,
after which, the research nurses contact each eligible
family to seek their verbal consent for study participa-
tion. Once verbal consent is obtained, a simple Informa-
tion Sheet containing only the names and telephone
numbers of the patient-family dyad as well as referring
nurses are forwarded to an appointed member of the
research team. The responsible researcher then contacts
the patient-family dyad via telephone to organize a
Table 2 Question framework of Family Dignity Intervention
Questions for patients
1. Tell me a little about your life history; what are some of the most
important and memorable times? When did you feel most alive?
2. How has your relationship with your loved one influenced your life?
3. What are some things you want your loved one to know about you,
or to remember about you?
4. What do you think are your most important and meaningful
accomplishments in life (family, career, community)?
5. What do you think your loved one is most proud of you for, or
appreciates about you?
6. What do you appreciate most about your loved one?
7. Are there particular things that you want to thank your loved one for?
8. Are there particular things that you would like to ask forgiveness for,
or offer forgiveness for?
9. What teachings, advice, or words of guidance do you want to pass
on to your loved one?
10. What are your hopes and dreams for the future, for yourself, your
loved one and your family?
11. In creating this permanent record, are there other things that you
would like to include?
12. Before the session ends, are there things that you would like to take
time to say again?
Questions for family caregivers
1. Tell me a little about your life history with your loved one; what are
some of the most important and memorable times you had
together? When did you feel most alive with your loved one?
2. How has your relationship with your loved one influenced your life?
3. What are some things you want your loved one to know about you,
or to remember about you?
4. What do you think are your loved one’s most important and
meaningful accomplishments in life (family, career, community)?
5. What do you appreciate most about your loved one?
6. What do you think your loved one is most proud of you for, or
appreciates about you?
7. Are there particular things that you want to thank your loved one for?
8. Are there particular things that you like to ask forgiveness for, or offer
forgiveness for?
9. What teachings, advice, or words of guidance have you received from
your loved one, and would like to pass on to other family members?
10. What are your hopes and dreams for future for your loved one,
yourself and your family?
11. In creating this permanent record, are there other things that you
would like to include?
12. Before the session ends, are there things that you would like to take
time to say again?
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convenient time for the first baseline assessment meet-
ing. All personal information pertaining to potential par-
ticipants is kept confidential and only the responsible
researchers have access to such information. Information
of the potential participants who refused to take part in
the study upon telephone contact are destroyed
immediately.
The first meeting is attended by the appointed FDI
therapist, as well as a responsible researcher who (1)
explains the study to the patient-family dyad, (2) answers
any questions that they may have about their participa-
tion, and (3) checks that they have fully understood the
implications of the study before obtaining written con-
sent. The consent form for this study is included as an
Fig. 1 Flow diagram of recruitment and study conduct
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Additional file 2. As a final check, the researcher screens
patients using the Mini Mental State Examination
(MMSE) [25] to assess cognitive functioning, and those
who score below 18 are considered unfit to participate.
In such cases, patient-family dyads are excluded; this is
done sensitively, whereby the researcher and the FDI
therapist spend some time chatting with the patient-
family dyads about neutral topics before ending the
meeting. This approach has worked successfully in pre-
vious studies of a similar nature [26].
For patient-family dyads who are deemed fit to partici-
pate after the final check, the researcher conducts a
baseline assessment with patients and caregivers indi-
vidually, then opens the next envelope in sequence to
ascertain group allocation. Dyads assigned to the control
group are reminded that they will receive three psycho-
social visits (four for caregivers) from the research team,
through which they will have the opportunity to share
their feelings along their illness trajectory. Dyads
assigned to the intervention group are given the FDI
framework questions, followed by a brief framing session
conducted by the FDI therapist. A time is then arranged
for the intervention interview session within the next 2
to 3 days.
After the intervention interview is completed and the
recorded transcript has been edited and finalized with
the patient-family dyad via a transcript review session,
the FDI therapist sets up a time for a final family sharing
session in which the “legacy” document is shared with
selected members of the patients’ family. A hard copy of
the legacy document is also given to the patient-family
dyad for safekeeping.
Outcome measures
Both quantitative outcomes (subjective and objective mea-
sures) as well as qualitative outcomes are assessed with
patients and family caregivers through face-to-face inter-
views. For patient-family dyads assigned to the intervention
group, these are assessed at four time points (see Fig. 2 for
the corresponding Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) Figure): during the
initial baseline assessment meeting (T1), approximately
14 days after baseline (i.e., 2 to 3 days after the legacy docu-
ments have been shared in the final family sharing session)
(T2), 4 weeks after baseline (i.e., 2 weeks after intervention
completion) (T3), and during an exit interview with family
caregivers after the patients’ death at 2 months post be-
reavement (T4) for assessing grief outcomes. Equivalent
assessments are conducted with patient-family dyads
assigned to the control group at the same four time points:
baseline assessment meeting (T1), approximately 14 days
(T2) and 4 weeks (T3) after baseline, as well as an exit
Fig. 2 Schedule of enrollment, intervention, and assessment
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interview with family caregivers at 2 months post bereave-
ment [T4]. All quantitative measures have been validated
with older populations, and demonstrated strong internal
consistency, test-retest reliability, construct and concurrent
validity. Some measures have been designed specifically for
end-of-life care research while others have frequently been
adopted in palliative care settings; all measures are used
widely in Asian contexts. Qualitative interview schedules
have been developed for this study.
Subjective outcome measures for patients
The primary outcome is patients’ sense of dignity (potential
effectiveness of FDI). This is assessed at baseline (T1),
14 days (T2), and 4 weeks’ follow-up (T3), using the Patient
Dignity Inventory [27]. This 25-item measure evolved
directly from the dignity model and is comprised of ques-
tions relevant to the physical, psychosocial, and spiritual
domain of end-of-life concern or distress. Secondary out-
comes are assessed using: Patient Health Questionnaire-9
[28] (psychological distress); a modified version of the Can-
cer Coherence Scale [29] (meaning in life); World Health
Organization Quality of Life Scale-8 [30] (quality of life);
FACIT Spiritual Well-being Scale [31] (spirituality); Herth
Hope Index [32] (hopefulness); and a modified version of
the Inventory of Social Support [33] (perceived support).
Subjective outcome measures for caregivers
The primary outcome is caregivers’ psychological dis-
tress (potential effectiveness of FDI). This is assessed at
baseline (T1), 14-day (T2), and 4-week (T3) follow-up,
as well as at 2 months (T4) post bereavement by the
Patient Health Questionnaire [28]. Secondary outcomes
are assessed using: a modified version of the Cancer
Coherence Scale [29]; World Health Organization Qual-
ity of Life Scale-8 [30]; FACIT Spiritual Well-being Scale
[31]; Herth Hope Index [32]; and a modified version of
the Inventory of Social Support [33]. Moreover, the Brief
Grief Questionnaire [34] and the Core Bereavement
Items [35] is used to assess grief and bereavement out-
comes at 2 months post bereavement.
Objective outcome measures for patient-family dyads
Heart rate variability (HRV), a reliable biomarker that
reflects an individual’s cardiovascular regulation, is used
to assess participants’ psychophysiological wellbeing.
Specifically, HRV scores are measured as the duration of
the inter-heartbeat interval, which mirrors balance in the
autonomic nervous system [36]. Higher HRV scores
indicate stronger responsiveness of the autonomic ner-
vous system in changing physiological arousal levels to
suit situational demands and life stressors, and serve as
a potential indicator of wellbeing and longevity; whereas
lower HRV scores indicate poor responsiveness of the
autonomic nervous system, which has been associated
with psychological conditions like anxiety and depres-
sion [37]. ithlete [38], a small non-invasive portable
HRV measurement device, together with a Smart tablet
installed with the ithlete HRV app, is used for this as-
sessment. Concisely, an infrared pulse plethysmography
finger sensor is attached to participants’ index finger
while following a series of brief breathing instructions
on the screen of the Smart tablet, and during this 1–
2-min exercises, data of their psychophysiological per-
formance are collected. As the procedure requires
participants to be in a restful state so as to minimize
the artefacts in heart rate data, HRV assessment is
conducted as the end of each face-to-face assessment
interview.
Demographic measures
To determine whether medical and demographic vari-
ables are potential confounding factors that affect
primary and secondary outcome variables, clinical infor-
mation (i.e., disease types, time since diagnosis, and
stages of disease) is collected from patients at baseline
assessment. Demographic data (i.e., age, gender, marital
status, family composition, living arrangements, educa-
tion, ethnicity, and religion) are also collected during
baseline assessment from both patients and family care-
givers. Information on the counseling service received is
also sought.
Qualitative outcome evaluation
Together with the quantitative assessment, a series of
simple, open-ended, evaluative questions are used to
seek participants’ insights into their evolving psycho-
social-spiritual needs along the illness trajectories, the
impact of FDI on themselves and their families, as
well as their views on taking part in this study. All
participants assigned to the intervention group who
have completed FDI are interviewed by an assigned
researcher at the third (T3) (for patients) and fourth
(T4) (for family caregivers) assessment time points; all
interviews are recorded and transcribed for analysis.
With participants’ consent, qualitative data analysis is
also carried out using the FDI transcripts to identify
insights into concerns which might impact interven-
tion effectiveness, as well as, narratives and stories of
dignity, hope, and meaning at life’s end.
Acceptability and feasibility assessment
To assess the implementation and delivery of FDI in com-
munity settings, time needed to organize and conduct the
intervention sessions, transcribe and edit narratives; devia-
tions from the intervention protocol, uncompleted inter-
ventions and their reasons; and the FDI therapists’
perceptions of competence as a result of training, are re-
corded. FDI therapists also record their experiences of
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delivering the intervention, their observations of patients’
and caregivers’ responses during and after the interven-
tion, as well as any difficult or unusual cases.
Data analysis
Quantitative data
All quantitative data are entered, stored, and analyzed
using SPSS statistical analysis software. Between- and
within-participant comparisons of outcomes are con-
ducted and the appropriate effect size estimates
reported. The intervention group and the control group
are compared on the main outcomes (sense of dignity
for patients; psychological distress for caregivers) and
secondary outcomes (psychological distress, meaning in
life, quality of life, spirituality, hopefulness, perceived
support, and psychophysiological wellbeing for patients;
meaning in life, quality of life, spirituality, hopefulness,
perceived support, psychophysiological wellbeing, and
bereavement outcome for caregivers). Comparisons are
done at T2 and T3 follow-ups with baseline for both
patient groups on these measures, as well as at T2, T3,
and T4 follow-ups with baseline for both caregiver
groups. To characterize and predict changes in outcome
variables, multilevel analyses are conducted. The inter-
vention and control groups are also compared on demo-
graphic characteristics and baseline measures. If
necessary, these are controlled in the analyses. Explora-
tory analyses on the influence of cultural, ethnical, and
religious factors on main outcomes and secondary out-
comes are also carried out. Finally, recruitment rates, as
well as comparisons of dropout rates and missing data
in the two groups are reported.
Qualitative data
The Framework method of analysis is used [39]. Analysis
is both deductive (from pre-set aims and objectives) and
inductive (arising from participants’ view). This method
tends to be more structured than some other methods
of qualitative analysis and the process is more explicit
and more informed by a priori questions. It is designed
so that it can be easily understood and assessed by
people other than the analysts such as funding bodies,
policy-makers, and participants. Throughout the analyt-
ical process, strategies to maximize credibility, criticality,
and authenticity are applied. The QSR NVIVO software
package is used to manage the data.
Discussion
In Asia and particularly in Singapore, Hong Kong,
China, Japan, Korea, and their southeastern neighbors,
demand for palliative care has surged over the past dec-
ade and will continue to rise in the future under the
context of population aging [40]. Regional and local gov-
ernments have honorably aspired to enhance the
provision of holistic palliative care to patients and fam-
ilies facing chronic and terminal illnesses. However,
most palliative interventions still focus predominately on
pain and symptom management without addressing
psycho-socio-spiritual concerns. To date, there is no
available palliative care intervention for dignity enhance-
ment in Singapore nor in Asia [20]. To address the crit-
ical gaps in the provision of holistic palliative care
services for patients and families facing terminal illness,
death, and bereavement, the research team designed a
randomized controlled trial that (1) integrates empirical
knowledge on end-of-life dignity-related needs and con-
cerns from both Western and Asian contexts, as well as
well-researched therapeutic model for dignity enhance-
ment, to form a culture-specific FDI for Asian palliative
care; (2) tests the effectiveness of this novel intervention
model (FDI) on enhancing the psycho-socio-spiritual
wellbeing of terminally ill patients and their families re-
ceiving palliative care in Singapore; and (3) establishes a
standardized intervention research protocol for further
testing of FDI in other societies across Asia that have
similar cultural and ethnic contexts.
The patient-family dyad intervention model of the FDI
supports the unique needs of Asian families who are not
accustomed to, or comfortable with, the expression of
emotions and affections even during times of loss and
separation [16, 17]. The lack of open communication
between patients and their family members prevents the
opportunities for reconciliation, resolving “unfinished
business,” as well as the expression of love and appreci-
ation, all of which are pivotal processes for minimizing
the existential pain of mortality. Creating a safe and car-
ing platform for patients and families to engage in such
intimate discourses could greatly elevate the experience
of dying, while reducing the psychosocial and spiritual
pain that is often deemed to be of greater concern to
older terminally ill patients than physical pain [18].
Authentic dialogues on life and death could further cul-
tivate empathetic understanding between patients and
their family caregivers, fostering the sense of filial com-
passion that imperatively fuels and sustains devotion to
family caregiving at life’s end [19]. This is of particular
importance in Asia given that many Asian governments
have established their policies for older people on no-
tions of aging in place and dying at home [40], both of
which accentuate the significant role that the family
plays in end-of-life caregiving. FDI could be a vital medi-
ator to support such policy agendas.
The FDI dyad intervention model could further pro-
mote family centered care, a highly valued provisional
practice of palliative services in Asia [20], one that tran-
scends conventional person-centered care in Western
societies. In fact, FDI could serve as the starting point to
engage patients and their families with professional
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caregivers in honest and constructive communications,
those that foster not only the expression of emotions, but
also encourage partnerships in familial and professional
caregiving, as well as cultivating informed participation in
the decision-making of end-of-life care treatments and
options. Repeated research has shown that joint participa-
tion in the governance of mortality between professional
caregivers and family caregivers is indispensable in allevi-
ating dying patients’ anxiety and depression, and minimiz-
ing unnecessary and futile treatments that may bring
more harm than good, in addition to reducing clinician-
patient-family conflicts that are often found amidst the
unmanaged chaos and confusions brought on by death
and dying [41]. This is also in line with national policies
on advance care planning (ACP) that have emerged across
Asia in recent years, whereby governments are beginning
to recognize the importance of promoting civil responsi-
bility in preparation for death and informed-care decision-
making at the end of life among members of the public. In
Singapore, for example, since 2011 the Ministry of Health
has invested millions of dollars in developing a national
ACP program [42]. But after years of effort and resources
spent on training health and social care workers to engage
patients and families in ACP conversations, less than
10,000 or so ACP conversations have been completed in
the past 6 years among a population of 5.5 million with
nearly 20,000 deaths per year [43]. This clearly reflects an
imminent need to develop better strategies to engage
patients and families in ACP discussions, and FDI can cer-
tainly pave the way for such dialogues to take place via
elevating the emotional readiness of patients and families
to talk openly and candidly about mortality.
In terms of the intervention protocol developed by this
study, its brief and systematic design will allow clinicians
to implement and assess the feasibility of adopting FDI
in different clinical and community care settings. The
transparent and meticulous evaluation design proposed
will also enable researchers to test its effectiveness in
promoting dignity and holistic wellbeing among different
population age groups facing terminal illness, not limited
to older adults. The inclusion of an exit assessment with
family caregivers during bereavement contributes to the
longitudinal database for studying grief outcomes, and
can further inform the development of other anticipa-
tory grief therapy and counseling modalities. Finally, the
inclusion of heart rate variability to measure the psycho-
physiological wellbeing of study participants provides
another innovative and objective method to assess the
effectiveness of a psycho-socio-spiritual intervention for
palliative care.
Limitations and recommendations
Despite the study’s strengths, some limitations do exist.
First of which is the limitation posed by involving only
two end-of-life care providers in the study, both of
which are established in-patient and home-care hos-
pices that are highly proficient in caring for the
dying and the bereaved. This may impact the out-
come of FDI given the high-quality standard care
rendered to patients and families; thus, future re-
search can expand study sites to include hospitals
and nursing homes to assess the acceptability and
effectiveness of FDI in primary, acute, and long-
term-care settings. Second, only patients who
attained a score of 30 and above from the KPSS are
deemed fit to participate in the study. This screen-
ing criterion may exclude individuals who are very
sick but may still have the capacity to engage in,
and benefit from, the FDI; hence, future studies and
clinical practices may consider lowering this criter-
ion to work with patients with sufficient functional
capacity to engage in a therapeutic narrative dia-
logue. Third, in consideration that terminally ill pa-
tients’ HRV may be affected by their physical states
as well as their prescribed medications, future re-
search may consider collecting relevant biometric
data, such as patients’ weight, height, and Body
Mass Index as well as the type of medications pre-
scribed, for cross-comparison and to ensure the val-
idity of HRV measurements [44]. Finally, due to the
limited language ability of the research team, FDI
can only be conducted with English-, Mandarin-
and Cantonese-speaking participants. While
Singapore is an ethnically diverse nation with many
residents of various cultural backgrounds and lan-
guage abilities [22], it is unreasonable to presume
that the findings generated from this study can be
applied to the majority of Asian populations. There-
fore, future research needs to expand the delivery
languages of FDI, as well as to assess its acceptabil-
ity and effectiveness among the many different eth-
nic groups in greater Asia.
With the aforesaid, this first-of-its-kind study
develops and tests an evidence-based and family
driven psycho-socio-spiritual intervention for enhan-
cing dignity and wellbeing among patients and fam-
ilies facing mortality. It addresses a critical gap in the
provision of holistic palliative care services. The ex-
pected outcomes should generate new knowledge
contributing to advancement in both clinical theories
and practices in palliative care for Singapore and its
neighboring regions, while serving to inform similar
developments in other Asian communities.
Trial status
The RCT is currently in month 10 of 36 planned months
of recruitment and data collection.
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